Publication & Citation Trends
Publications
0 total
Abstract 1923: KRAS-mutant (mt) colorectal cancer (CRC) organoid models generated from patient-derived xenografts (PDX) show response to combination of trametinib (Tm), neratinib (N), and trastuzumab (Tz) OA
Cited by 1
Semantic Scholar
Abstract LB-087: Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status
Cited by 0
Semantic Scholar
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations OA
Cited by 9
Semantic Scholar
Abstract 5167: Stem-like colorectal cancer cell lines show response to the ERK1/2 inhibitor, SCH772984, alone and in combination with neratinib
Cited by 1
Semantic Scholar
Abstract 5684: NSABP FC-7 correlative study: HER2 amplification (amp) in circulating cell-free DNA (cfDNA) in metastatic colorectal cancer (mCRC) resistant to anti-EGFR therapy (tx)
Cited by 1
Semantic Scholar
microRNA-10b Is Overexpressed and Critical for Cell Survival and Proliferation in Medulloblastoma OA
Cited by 25
Semantic Scholar
Abstract 706: Inflammatory and stem-like colorectal cell lines show differential response to MEK-162 and neratinib in combination
Cited by 0
Semantic Scholar
Abstract 3082: miRNA-10b promotes medulloblastoma proliferation and survival via Bcl-2.
Cited by 0
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(8)
Colorectal Cancer Treatments and Studies
(7)
Prostate Cancer Diagnosis and Treatment
(5)
Cancer Genomics and Diagnostics
(5)
Hepatocellular Carcinoma Treatment and Prognosis
(4)
Affiliations
University of Leicester
University of Pittsburgh
Northampton General Hospital
University Hospitals of Leicester NHS Trust
State of The Art